Systemic Therapy for Advanced Pancreatic Cancer in 2025: Current Standard-of-Care and Emerging Therapeutic Strategies.
This publication is a narrative review of current and emerging systemic treatments for advanced pancreatic cancer, with...
A MULTIMODAL STOOL RNA, FIT AND MACHINE LEARNING CONCEPT FOR DETECTION OF ADVANCED PRECANCEROUS LESIONS AND COLORECTAL CANCER.
- Post category:Digestive (CRC, Stomach) System
- Reading time:1 min read
This study evaluated a noninvasive multimodal stool RNA test (mm-stRNA) that combines five human mRNA biomarkers with a...
The impact of exercise on tolerability of systemic treatment in metastatic colorectal cancer: A literature review.
- Post category:Digestive (CRC, Stomach) System
- Reading time:3 mins read
This narrative review examines whether structured physical activity can mitigate treatment-related toxicity in metastati...
A paradigm shift in genetic predisposition to colorectal cancer: the impact of germline multigene panel testing on diagnosis and management.
- Post category:Digestive (CRC, Stomach) System
- Reading time:2 mins read
This review article focuses on hereditary colorectal cancer (HCRC) in the era of next-generation sequencing and multigen...
First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial.
- Post category:Digestive (CRC, Stomach) System
- Reading time:1 min read
Phase 2 ILUSTRO cohort 4 evaluated adding zolbetuximab (anti‑CLDN18.2) and nivolumab to mFOLFOX6 as first‑line thera...
Zolbetuximab for gastroesophageal adenocarcinoma: drug review and lessons from the frontlines.
- Post category:Digestive (CRC, Stomach) System
- Reading time:2 mins read
This article reviews early real‑world experience incorporating zolbetuximab into routine care for advanced gastric and...